Translational Research Related Content

Dr. Weiss’ career has focused on treatment and clinical research with substance-dependent patients. He has received numerous NIH grants, including for developing integrated group therapy, an evidence-based treatment for co-occurring bipolar and substance use disorders, and leading a multi-site...

Shelly F. Greenfield, MD, MPH, is an addiction psychiatrist, clinician, and researcher. She serves as principal and co-investigator on federally funded research focusing on substance use disorders treatment, gender differences, and substance health services. She received a National Institute on Drug...

Bruce M. Cohen, MD, PhD, leads a multidisciplinary research program on the causes of psychiatric disorders, with the goal of developing new, more effective, and better tolerated treatments. He and his colleagues employ pharmacologic, brain imaging, epidemiologic, genomic, and cell model approaches...

J. Alexander Bodkin, MD, has been at McLean since 1985. Working with Dr. Jonathan Cole until his death, Dr. Bodkin has long pursued the study of new and old medications for depression and anxiety. His research has focused on underutilized pharmacologic approaches to difficult-to-treat mood and...

Marc L. Copersino, PhD, ABPP-CP, is affiliated with the Division of Alcohol, Drugs, and Addiction and works collaboratively with members of the McLean Imaging Center. He conducts patient-oriented research focusing on the clinical neuroscience and treatment of substance use disorders (SUD) in two...

As director of the Laboratory for Computational Neuroscience, Dr. Siekmeier’s research centers on the computational modeling of the hippocampus, an area of brain thought to be responsible for encoding memories, and one that has been implicated in the etiology of schizophrenia. The goals of this...

As a graduate of University of Heidelberg Medical School, Dr. Sonntag studied the molecular biology of viruses, and as a research fellow at the Transplantation Biology Research Center at Massachusetts General Hospital, he conducted research in transplantation immunology. In 2000, he joined McLean...

Ann K. Shinn, MD, MPH, is the director of clinical research in the Schizophrenia and Bipolar Disorder Research Program, and an assistant professor of psychiatry at Harvard Medical School. From 2013-2017, she was the co-medical director of McLean OnTrack, an intensive outpatient program specializing...

Daniel G. Dillon, PhD, was trained in human neuroscience at Duke University, where he studied learning and memory under the guidance of Dr. Kevin LaBar. As a post-doctoral fellow working with Dr. Diego Pizzagalli at Harvard University, Dr. Dillon investigated brain systems implicated in anhedonia, a...

Mei-Hua Hall, PhD, is the director of the Psychosis Neurobiology Laboratory. Her specific expertise is in electrophysiology, psychiatric genetics, and cognitive neuroscience and she also has a broad background in clinical psychology, epidemiology, and statistical modeling. She receives funding from...

James I. Hudson, MD, ScD, SM, received his MD from Tufts University Medical School of Medicine and his ScD and SM degrees from Harvard School of Public Health. Joining McLean Hospital in 1980, he is currently a professor of psychiatry at Harvard Medical School, and director of the Biological...

David H. Rosmarin, PhD, is the director of the Spirituality and Mental Health Program at McLean Hospital and an associate professor of psychology in the Department of Psychiatry at Harvard Medical School. He received his PhD in clinical psychology from Bowling Green State University under the...

Bertha K. Madras, PhD, is a professor of psychobiology at Harvard Medical School, based at McLean Hospital and cross appointed at the Massachusetts General Hospital. Her research focuses on neurobiology, imaging, and medications development (19 U.S. and 27 international patents) for neuropsychiatric...

Sabina Berretta, MD, began her research training under the mentorship of Dr. V. Perciavalle at University of Catania, Italy. In 1990, she joined the laboratory directed by Dr. A. M. Graybiel in the Department of Brain and Cognitive Sciences at MIT, working neural circuitry linking the motor cortex...

Diego A. Pizzagalli, PhD, is founding director of the Center for Depression, Anxiety and Stress Research, director of the McLean Imaging Center, director of the Laboratory for Translational and Affective Neuroscience, and director of research for the Division of Depression and Anxiety Disorders at...

The director of the Laboratory for High-Field Imaging and Translational Neuroscience and the Advanced MRI/MRS Core in the McLean Imaging Center (MIC), Dr. Fei Du is a neuroimaging biophysicist with a background in magnetic resonance imaging and spectroscopy (MRI/MRS). After training in the technical...

Dr. Ole Isacson is a professor of neurology at Harvard Medical School and founding director of the Neuroregeneration Research Institute at McLean Hospital. His work is focused on the understanding and treatments of neurodegenerative disease, with particular emphasis on distinguishing critical...

R. Kathryn McHugh, PhD, engages in clinical and translational research focusing on the nature and treatment of anxiety and addiction. She is particularly interested in the study of affective vulnerability factors, such as distress intolerance and stress reactivity, that are common across...

Courtney Beard, PhD, is an associate professor of psychology in the Department of Psychiatry at Harvard Medical School, and at McLean Hospital serves as director of the Cognition and Affect Research and Education (CARE) Laboratory and co-director of the Behavioral Health Partial Hospital Clinical...

Alaptagin Khan, MBBS, FRSPH, is a research associate at McLean Hospital and an instructor in psychiatry at Harvard Medical School. After graduating from medical school, Dr. Khan took the opportunity to work with the Red Cross and UNICEF in conflict zones where he developed an interest in PTSD and...